NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1
NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1
复制标题
DOI:
10.1161/01.hyp.0000153051.56460.6a
复制
发表时间:
2005-02-01
期刊:
影响因子:
8.3
通讯作者:
Pollock, DM
中科院分区:
文献类型:
--
作者:
Elmarakby, AA;Loomis, ED;Pollock, DM
Experiments were conducted to test the hypothesis that hypertension produced by chronic ET-1 infusion is mediated by NADPH oxidase-dependent superoxide production. Mean arterial pressure ( MAP) was continuously monitored in male Sprague Dawley rats by telemetry. After baseline measurements, rats were placed on a high-salt diet (8% NaCl) and osmotic minipumps were implanted to infuse ET-1 ( 5 pmol/kg per minute intravenous) for 12 days. Control rats were maintained on the high-salt diet only. Separate groups of rats were also infused with ET-1 and given the superoxide dismutase mimetic, tempol ( 1 mmol/L), or the NADPH oxidase inhibitor, apocynin (1.5 mmol/L), in the drinking water. Infusion of ET-1 significantly increased MAP when compared with baseline values ( 132 +/- 3 versus 114 +/- 2 mm Hg, P < 0.05). Neither tempol nor apocynin treatment had any effect on the increase in MAP produced by ET-1 when compared with baseline values ( 127 +/- 5 versus 113 +/- 2 and 130 +/- 3 versus 115 +/- 2 mm Hg, respectively). Plasma 8-isoprostane, an indicator of oxidative stress, was significantly increased in ET-1-infused rats compared with rats on a high-salt diet alone ( 128 +/- 33 versus 51 +/- 5 pg/mL; P < 0.05). Both tempol and apocynin treatment significantly attenuated the ET-1-induced increase in plasma 8-isoprostane ( 72 +/- 10 and 61 +/- 6 pg/mL, respectively). Similarly, ET-1 infusion also significantly increased aortic superoxide production ( chemiluminescence and dihydroethidium staining techniques), which was prevented by both tempol and apocynin. These data provide evidence that chronic ET-1 infusion increases vascular NADPH oxidase-dependent superoxide production but does not account for chronic ET-1-induced hypertension.